Phillips AN - Search Results

1

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.

Mocroft A, Phillips AN, Miller V, Gatell J, van Lunzen J, Parkin JM, Weber R, Roge B, Lazzarin A, Lundgren JD; EuroSIDA study group. Mocroft A, et al. Among authors: phillips an. AIDS. 2001 Jan 26;15(2):201-9. doi: 10.1097/00002030-200101260-00009. AIDS. 2001. PMID: 11216928 Clinical Trial.

2

Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group.

Lundgren JD, Barton SE, Lazzarin A, Danner S, Goebel FD, Pehrson P, Mulcahy F, Kosmidis J, Pedersen C, Phillips AN. Lundgren JD, et al. Among authors: phillips an. Clin Infect Dis. 1995 Jul;21(1):106-13. doi: 10.1093/clinids/21.1.106. Clin Infect Dis. 1995. PMID: 7578718

3

HIV results in the frame. Antiviral therapy.

Phillips AN, Sabin CA, Mocroft A, Janossy G. Phillips AN, et al. Nature. 1995 May 18;375(6528):195; author reply 198. doi: 10.1038/375195a0. Nature. 1995. PMID: 7746315 No abstract available.

4

Serum HIV-1 RNA and routine patient monitoring.

Phillips AN, Sabin CA, Mocroft A. Phillips AN, et al. Lancet. 1995 Jun 3;345(8962):1441. Lancet. 1995. PMID: 7760634 No abstract available.

5

Active drug injecting and progression of HIV infection.

Phillips AN, Sabin CA, Mocroft A. Phillips AN, et al. AIDS. 1994 Mar;8(3):385-6. doi: 10.1097/00002030-199403000-00014. AIDS. 1994. PMID: 8031518 Review. No abstract available.

6

CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.

Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G. Phillips AN, et al. AIDS. 1993 Jul;7(7):975-80. doi: 10.1097/00002030-199307000-00011. AIDS. 1993. PMID: 8102854

7

Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.

Janossy G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, Lipman M, Johnson MA, Lee C, Bofill M. Janossy G, et al. Among authors: phillips an. AIDS. 1993 May;7(5):613-24. doi: 10.1097/00002030-199305000-00002. AIDS. 1993. PMID: 8318170

8

The use of CD4 counts as prognostic markers in HIV infection.

Sabin CA, Mocroft A, Phillips AN. Sabin CA, et al. Among authors: phillips an. AIDS. 1995 Oct;9(10):1205-6. doi: 10.1097/00002030-199510000-00021. AIDS. 1995. PMID: 8519466 No abstract available.

9

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.

Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G. Bofill M, et al. Among authors: phillips an. AIDS. 1996 Jul;10(8):827-34. doi: 10.1097/00002030-199607000-00005. AIDS. 1996. PMID: 8828739

10

HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.

Phillips AN, Eron JJ, Bartlett JA, Rubin M, Johnson J, Price S, Self P, Hill AM. Phillips AN, et al. AIDS. 1996 Jul;10(8):859-65. doi: 10.1097/00002030-199607000-00009. AIDS. 1996. PMID: 8828743 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters